Hypoxia Inducible Factor (HIF) is the master transcriptional regulator that orchestrates cellular 30 adaptation to low oxygen. HIF is tightly regulated via the stability of its α-subunit, which is 31 subjected to oxygen-dependent proline hydroxylation by Prolyl-Hydroxylase Domain 32 containing proteins (PHDs/EGLNs), and ultimately targeted for proteasomal degradation 33 through poly-ubiquitination by von-Hippel-Lindau protein (pVHL). However, sustained HIF-α 34 signalling is found in many tumours independently of oxygen availability pointing towards the 35 relevance of non-canonical HIF-α regulators. In this study, we establish the Ubiquitin Specific 36
Introduction
4 proteins, USP20 (also called pVHL interacting deubiquitinating enzyme 2, VDU2), MCPIP1, 83 USP8 and UCHL1 emerged as new HIF-α regulators, as they reverse the canonical HIF-α 84 ubiquitination. Furthermore, USP28 antagonizes Fbw7-mediated HIF-1α degradation, and 85 Cezanne (OTUD7B) protects HIF-1α from lysosomal degradation, and are therefore 86 implicated in the non-canonical HIF-1α regulation (Altun et al, 2012; Bremm et al, 2014; Flugel 87 et al, 2012; Goto et al, 2015; Li et al, 2005; Roy et al, 2013; Troilo et al, 2014) . Surprisingly, 88 to date no DUB has been shown to exhibit hydrolase activity towards In 2000 a new gene in the Peg3 (paternally expressed gene 3) region was discovered. Like 90 all genes in this region, it was shown to be imprinted and, in this specific case, to be paternally 91 expressed. Due to its structural homology with the ubiquitin specific proteases (USPs), the 92 biggest class of DUBs, it was named USP29. USP29 mRNA was only detectable by Northern 93
Blot in murine brain and in testis of mice and humans (Kim et al, 2000) . It was not until 2011 94 that the first biological function of the 922 aa long USP29 gene product was described and 95 showed that H2O2 treatment induced the expression of USP29 (Liu et al, 2011) . They reported 96 that USP29 bound to p53 and stabilised it by decreasing its ubiquitination. A few years later, 97 USP29 was also described to bind to the cell cycle checkpoint adapter claspin and that USP29 98 silencing reduced basal claspin levels (Martin et al, 2015) . Here, we show that USP29 is a 99 novel non-canonical regulator of both HIF-1α and HIF-2α. USP29 binds to HIF-α in an oxygen-100 independent manner, deubiquitinates it and therefore rescues HIF-α from proteasomal 101 degradation. 102 103 5
Results

104
USP29 is a positive regulator of HIF-1α 105 The hypoxia pathway is under exquisite control by reversible ubiquitination. In order to identify 106 hypoxia specific deubiquitinating enzymes (DUBs), we carried out an unbiased loss-of function 107 screen using pools of small hairpin RNAs (shRNAs) to individually inhibit the expression of 66 108 human DUBs and the hypoxia-driven LUC reporter. USP29 came up as one of the strongest 109 hits from three independent screenings carried out in triplicates. Indeed, the silencing of 110 endogenous USP29 with a pool of 3 independent shRNAs in HeLa cells significantly reduced 111 the hypoxia-driven HRE-luciferase expression ( Figure 1A ). In concordance with this data, 112 silencing of endogenous USP29 also abrogated the hypoxic induction of the HIF target gene 113 CA9 ( Figure 1B) . The pool of shUSP29s efficiently silenced GFP-USP29 at mRNA and protein 114 levels (Expanded View Figure 1A ). Interestingly, in cells silenced for endogenous USP29 the 115 accumulation of HIF-1α protein in hypoxia was significantly decreased and the induction of 116 CAIX and PHD2 was impaired to a similar extent as when silencing HIF1A ( Figure 1C ). 117
Anyhow, HIF1A mRNA was not affected by the silencing of USP29 (Expanded View Figure  118 1B). More importantly, similar to the pan-hydroxylase inhibitor DMOG, the ectopic expression 119 of USP29 led to the accumulation of endogenous HIF-1α, CAIX and PHD2 even in normoxia 120 ( Figure 1D ). Nonetheless, HIF1A mRNA expression was not affected by the USP29 121 overexpression (Expanded View Figure 1C ), pointing to USP29 as a novel upstream post-122 translational activator of HIF-1α. 123
USP29 upregulates HIF-1α in a non-canonical way
124 Surprisingly, the HIF-1α that accumulated in the presence of USP29 in normoxic conditions 125 induced PHD2 and CAIX ( Figure 1D ), albeit being prolyl-hydroxylated ( Figure 2A) . 126 Furthermore, the ectopic expression of USP29 also accumulated HIF-1α DM (PP/AA) , a HIF-1α 127 mutant whose two oxygen-sensitive proline residues have been replaced by alanines 128 (P402/564A), suggesting that USP29 regulates HIF-1α in a non-canonical way ( Figure 2B ). 129 6 Consistently, silencing of endogenous USP29 with 2 different siRNA sequences decreased 130 both, HIF-1α WT and HIF-1α DM (PP/AA) protein levels ( Figure 2C and Expanded View Figure  131 2A). As expected, the silencing of the canonical negative regulators, PHD2/EGLN1 and pVHL, 132 only affected HIF-1α WT but not HIF-1α DM (PP/AA) ( Figure 2C) . Similarly, the overexpression 133 of the Ub E3-ligase pVHL did only affect HIF-1α WT, but not the DM protein (Expanded View 134 Figure 2B ). Taken together, these results indicate that USP29 acts on HIF-1α through a non-135 canonical mechanism. 136
Universality of USP29's effect on HIF-α 137
The effect of USP29 on HIF-1α was observed in a variety of cell lines of different origins, 138
including A2780 (ovarian cancer), PC3 and LnCaP (prostate cancer), SH-SY5Y and SK-N-AS 139 (neuroblastoma) and MDA-MB-231 (breast cancer). In all tested cell lines the overexpression 140 of USP29 led to an increase in HIF-1α DM (PP/AA) levels ( Figure 3A ), indicating that this 141 regulation might be a wide phenomenon. Interestingly, not only HIF-1α but also both, the wild 142 type and the oxygen-insensitive DM (PP/AA) forms of HIF-2α/EPAS accumulated upon 143 overexpression of USP29 ( Figure 3B ). 144
USP29 stabilises HIF-α by protecting it from proteasomal degradation 145
In order to determine the molecular mechanism of HIF-α DM (PP/AA) accumulation by USP29, 146
we treated HEK293T cells with the proteasome inhibitor MG132 for 4 hours in the absence or 147 presence of ectopic USP29 ( Figure 4A ). Both, the USP29 overexpression and the proteasome 148 inhibition induced HIF-1α DM (PP/AA) accumulation, but the lack of additivity indicated that they 149 both acted on the same pathway. Furthermore, as USP29 accumulated HIF-1α DM (PP/AA) more 150
efficiently than MG132, we tested whether HIF-1α DM (PP/AA) was also degraded via the 151 lysosomal pathway. Yet, the inhibition of this pathway by treatment with chloroquine failed to 152 prevent HIF-1α DM (PP/AA) degradation (Expanded View Figure 3A ), confirming that it requires 153 the proteasome activity and suggesting that the difference between MG132-and USP29-154 induced HIF-1α DM (PP/AA) accumulation was due to incomplete proteasome inhibition.
7
Cycloheximide experiments showed that USP29 increased HIF-1α DM (PP/AA) 's half-life from ≅ 156 1 to ≅3 hours (Expanded View Figure 3B ). More importantly, USP29 stabilised endogenous 157 HIF-1α upon reoxygenation ( Figure 4B ). Although USP29 did not avoid the initial HIF-1α 158 degradation within the first 10 minutes of reoxygenation, thereafter HIF-1α levels remained 159 stable during at least one hour in the presence of USP29, while the protein was not longer 160 detectable 30 minutes after reoxygenation in the absence of USP29. To gain further insight 161 into how USP29 stabilised HIF-α, we generated a catalytically inactive USP29 mutant by 162 replacing its active site cysteine residue C294 with a serine (USP29 C/S ). This mutation 163 completely abrogated USP29's ability to accumulate HIF-1α DM (PP/AA) ( Figure 4C 
167
As the catalytical activity of USPs is responsible for removal of (poly)ubiquitin chains from their 168 target proteins, we next tested whether USP29 was able to function as a deubiquitinase for 169 HIF-α. We first analysed USP29 and HIF-α interaction using fluorescence lifetime based FRET 170 measurements. The fluorescence lifetime of the FRET donor, Clover-HIF-1α DM (PP/AA) , was 171 significantly decreased from 2.86 ± 0.02 ns to 2.7 ± 0.09 ns in the presence of the FRET 172 acceptor mCherry-USP29 ( Figure 5A ). As FRET only occurs when both fluorophores are in 173 very close proximity (around 6 nm), these data clearly show that USP29 is directly bound to 174 HIF-1α DM (PP/AA) . Similar results were obtained when we analysed the interaction between 175 USP29 and HIF-2α DM (PP/AA) (Expanded View Figure 4A ). HIF-2α DM (PP/AA) -GFP's lifetime was 176 significantly reduced from 2.39 ± 0.01 ns to 2.28 ± 0.06 ns in the presence of the FRET 177 acceptor mCherry-USP29. Furthermore, when GFP-tagged HIF-1α DM (PP/AA) or GFP alone 178 were immunoprecipitated from HEK293T cells, we found HA-USP29 to interact with GFP-179 tagged HIF-1α DM (PP/AA) , but not with GFP alone (Expanded View Figure 4B ). Next, we 180 cotransfected GFP-tagged HIF-1α DM (PP/AA) together with FLAG-ubiquitin either in the 181 absence or the presence of HA-USP29 or HA-USP29 C/S . After the enrichment of the 182 ubiquitinated proteome by MG132-treatment, GFP-HIF-1α DM (PP/AA) was pulled-down under 183 highly denaturing conditions and anti-FLAG-antibody was used to detect ubiquitinated GFP-184 HIF-1α DM (PP/AA) . We found that USP29 wild type, but not the catalytically inactive USP29 C/S , 185
considerably decreased the basal ubiquitination of HIF-1α DM (PP/AA) and increased the non-186 modified population of HIF-1α DM (PP/AA) ( Figure 5B ). Accordingly, when silencing endogenous 187 USP29, we observed increased poly-ubiquitination of HIF-1α DM (PP/AA) ( Figure 5C Figure 6A ). The USP29 C/S mutant that lacked catalytical activity was not able to accumulate 200 HIF-1α 630-826 (Expanded View Figure 5A ). Correspondingly, USP29 acted also on the C-201 terminus of HIF-2α (Expanded View Figure 5B ). We used truncations of the C-terminus to 202 further confine the USP29 target site within HIF-1α. HIF-1α 630-713 and HIF-1α 630-750 were 203 resistant to USP29-mediated accumulation (Expanded View Figure 5C ) and pointed out the 204 importance of the very C-terminal tail of HIF-1α for this regulation. This tail contains two 205 evolutionary conserved lysines (K752 and K755), which are also shared by HIF-2α and a 206 neighbouring lysine (K758) (Expanded View Figure 5D ). Mutation of all three lysines to 207 arginines (HIF-1α DM KKK/RRR ) conferred to this mutated protein a higher stability in 208 9 cycloheximide experiments ( Figure 6B ). Importantly, the basal ubiquitination of HIF-1α 209 DM KKK/RRR was significantly reduced as compared to HIF-1α DM ( Figure 6C ). 210
USP29 levels correlate with tumour progression and HIF target gene
The fact that USP29 stabilises HIF-α and is able to maintain hypoxia signalling switched on in 213 normoxic conditions, led us to inquire its potential function in tumour progression. We therefore 214 assessed whether USP29 expression was altered in certain tumours. Data mining analysis of 215 publicly available databases revealed that USP29 expression was significantly correlated with 216 prostate cancer progression ( Figure 7A ). The expression levels of USP29 mRNA increased 217 from normal tissue over primary tumour to metastasis. Interestingly, USP29 expression 218 exhibited a significant association with the Gleason Score (GS), used in the clinics to stratify 219 prostate cancer patients and predict their prognosis, as reflected by higher GS associated with 220 higher USP29 expression levels ( Figure 7B ). Furthermore, in the prostate cancer samples the 221 expression of USP29 also showed a significant positive correlation with the expression levels 222 of the HIF target gene CA9 ( Figure 7C ). 223 224
Discussion
225
As the master transcription factor for hypoxia induced genes, HIF is the central component of 226 cellular oxygen sensing. However, the pathway can be active even in the absence of hypoxia 227 and HIF-α expression does not always correlate with tissue oxygenation. Notably, sustained 228 HIF signalling occurs in many pathological conditions including cancer and inflammatory 229 diseases pointing towards the relevance of non-canonical regulators of the HIF pathway. In 230 the present study, we reported a novel insight into these regulatory mechanisms via USP29. 231
We provided clear evidence that the ubiquitin specific protease 29 (USP29) is a new non-232 canonical and direct positive regulator of HIF-α stability in a panel of different cell lines. USP29 233 bound to poly-ubiquitinated HIF-α, is responsible for its deubiquitination and hence protects it 234 from proteasomal degradation. Importantly, the stabilised HIF-α, while still prolyl-hydroxylated, 235
is transcriptionally active. We also showed that even the oxygen-insensitive form of HIF-α, 236
HIF-α DM (PP/AA) , could still be degraded by the proteasome upon poly-ubiquitination. 237
Furthermore, USP29 is able to reverse this ubiquitination and extend the half-life of the protein. target HIF-α on its C-terminal end where we found USP29 to act on. We have identified a 250 cluster of three lysine residues (K752, K755 and K758) located at the very C-terminal tail of 251 HIF-1α as potential USP29 target site(s). As a matter of fact, the mutation of these residues 252 to arginine almost completely abolished the basal ubiquitination and stabilised the mutated 253 protein. However, we were unable to confirm by mass spectrometry that any of those lysines 254 were indeed ubiquitinated as they weren't resolved in the analysis, even though K48-linked 255 polyubiquitin was present in the samples. The relevant sequence context suggested that 256 fragmented peptides were either too long or too short to be resolved by MS. 257
Our attempts to identify the ubiquitin E3 ligase that ubiquitinates HIF-α on those lysines and 258 therefore counteracts USP29 function have so far been unsuccessful. Nevertheless, we 259 hypothesise that this Ub E3 ligase might have a crucial role in triggering HIF-α proteasomal 260 degradation in a prolyl-hydroxylation-independent manner and could switch HIF signalling off 261 even in hypoxic conditions. The phosphorylation of HIF-1α by ATM and PKA at S692 and 262 S696, respectively has been suggested to increase its stability (Bullen et al, 2016; Cam et al, 263 2010) . Even though the effect of these kinases on HIF-2α has not been reported, the close 264 proximity of the serine residues to the USP29-targeted lysines make it tempting to speculate 265 that phosphorylation might increase or decrease the binding of USP29 and the relative Ub E3 266 ligase to HIF-α, respectively, and thereby determine HIF-α's ubiquitination pattern and 267 consequent stability. 268
To date, USP29 has been reported to exhibit deubiquitinase activity towards p53 and claspin, 269 both proteins that are associated with carcinogenesis. The novel effect we now report on HIF-270 α protein levels expands the impact of USP29 in cancer. Since USP29 is involved in the 271 regulation of key cellular processes such as HIF signalling and DNA integrity, it is not 272 surprising to find USP29 expression to be very tightly controlled in healthy cells, 273 transcriptionally and also potentially post-translationally. USP29, also known as HOM-TEST-274 84/86, is an imprinted gene located on chromosome 19q13.43 and encodes a protein of 922 275
Aa (Kim et al., 2007) . As its neighbouring gene Peg3, USP29's maternal allele is inactivated 276 by imprinting and as a consequence, we and others found endogenous USP29 mRNA and 277 protein levels barely above background by qPCR and Western Blot, respectively, using 278 commercially available antibodies for protein detection (Kim et al, 2000; Liu et al, 2011) . The identification of USP29 as an important regulator of HIF-α provides a novel mechanism 292 to explain the constitutive expression of HIF-α reported in many tumours independently of 293 oxygen availability. Overexpression or hyperactivity of USP29 would therefore cause 294 sustained HIF signalling, for which we found evidence in prostate cancer. However, it remains 295 to be confirmed whether in these tumours HIF deubiquitination is indeed abnormally regulated. 296
Alternatively, the loss of the respective so far unknown Ub E3 ligase or the mutation of the 297 USP29 target lysines could provide a selective advantage for tumour cells. In this regard, a 298 thorough sequencing effort in a broad range of tumours is needed to determine whether the 299 site that we identified is mutated in human cancers and whether mutations evolve in metastatic 300 progression or with drug-resistance. We found the mRNA expression levels of USP29 being 301 associated with GS in prostate cancer, which suggests that USP29 may potentially serve as 302 a prognostic marker. Finally, our results suggest that USP29 inhibitors could be used to switch 303 HIF signalling off as a useful strategy in combination with current chemotherapies. In this 304 13 context, it is worthy to note that USP29, having a cysteine protease catalytical site, is a 305 potentially druggable protein. 306
Taken together, our study provides a rationale to make USP29 an important target for future 307 studies. The further characterisation of the enzyme, its regulation and target proteins are 308 crucial steps in order to understand how to tackle its deregulation. 309 For delivery of siRNA or DNA to the cell, cells were transfected in suspension at plating or 24 335 h post-seeding at 60-70% confluence, respectively, using Lipofectamine 2000 (Invitrogen) as 336 a transfection reagent following manufacturer's instructions ( Table 2 summarizes in Table 3 . PCR was carried out in a CFX96™ Thermal cycler (Bio-Rad). The expression of 351 each target mRNA relative to RPLP0 was calculated based on the threshold cycle (Ct) as 2 -352 Δ (ΔCt) . 353
Materials and methods
Ubiquitination assay, co-immunoprecipitation and immunoblotting 354
Ubiquitination assays were performed as described previously (Lee et al, 2014) . Essentially, 355
HEK293T cells were co-transfected with FLAG-tagged ubiquitin together with the expression 356 vector of the GFP-tagged protein of interest. Cell were treated with MG132 (10 μM) for 2h prior 357 to lysis with lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5% Triton X-358 100, 40 mM β-Glycerolphosphate, 1 μg/ml Leupeptin, 1 μg/ml Aprotinin, 1 μg/ml Pepstatin A, 359 7 mg/ml N-ethylmaleimide (NEM)). Precleared lysates were incubated for 2.5h at RT with pre-360 washed GFP-traps® (Chromotek) and subsequently subjected to stringent washes in 361 denaturing conditions (8 M urea, 1% SDS). Protein was eluted by boiling at 95ºC for 5 min 362 (250 mM Tris-HCl pH 7.5, 40% glycerol, 4% SDS, 0.2% bromophenol blue, 5% β-363 mercaptoethanol) and migrated on 4-15% Tris-glycine gradient gels (BioRad). 364
Co-immunoprecipitation assays were performed as ubiquitination assays but cells were lysed 365 in the absence of NEM (50 mM Tris-HCl (pH 8), 120 mM NaCl, 1 mM EDTA, 1 % IGEPAL CA-366 630, 40 mM β-Glycerolphosphate, 1 μg/ml Leupeptin, 1 μg/ml Aprotinin, 1 μg/ml Pepstatin A). 367
Lysates were precleared by incubating with agarose beads (Chromotek) prior to overnight 368 incubation with the GFP-traps® and mild washes were performed with detergent-free non-369 denaturing lysis buffer. Protein complexes were eluted and migrated as described above. 370
For total cell extracts, cells were lysed with Laemmli buffer (50 mM Tris-HCl pH 6.8, 1.25% 371 SDS, 15% glycerol) and total protein was quantified using the Lowry assay. Proteins were 372 separated by SDS-PAGE and transferred onto a PVDF membrane (Millipore). The following 373 antibodies were used for immunoblotting: mouse anti-β-actin (A5441, Sigma-Aldrich), mouse 374 anti-CAIX (clone MN75, Bayer), mouse anti-FLAG-HRP (F3165, Sigma-Aldrich), mouse anti-375 GFP (11814460001, Roche), mouse anti-HA.11 (MMS-101R, Covance), rabbit anti-HIF-376 P564OH (D43B5, Cell Signaling Technology), anti-LC3 (2775s, Cell Signaling Technology), 377 mouse anti-myc (9B11, Cell Signalling Technology). Home made rabbit anti-HIF1α and anti-378 PHD2 antibodies have been previously described (Berra et al, 2003) . Immunoreactive bands 379
were visualized with ECL. 380 (dependence) between two variables X and Y, giving a value between +1 and −1 (both 404 included), where 1 is total positive correlation, 0 is no correlation, and −1 is total negative 405 correlation. The p-value indicates the significance of this R coefficient. The confidence level 406 used in this case was also of 95% (alpha value = 0.05 
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A HEK293T cells were transfected with empty vector or HA-USP29 and treated with the 570 hypoxia mimetic DMOG (1 mM), the proteasome inhibitor MG132 (10 μM) or hypoxia (1% O2) 571 for 4 hours. WCE were prepared and analysed by immunoblotting with the indicated 572 antibodies. 573 B HEK293T cells were co-transfected with myc-HIF-1α or myc-HIF-1α DM (PP/AA) and empty 574 vector or GFP-USP29. Levels of myc-and GFP-tagged proteins in WCE were determined by 575 immunoblotting in WCE. 576 C HEK293T cells were silenced with control or siRNAs (20 nM) targeting endogenous USP29, 577 PHD2/EGLN1 or pVHL mRNA and transfected with myc-HIF-1α or myc-HIF-1α DM (PP/AA) . Total 578 cell extracts were subjected to SDS-PAGE followed by immunoblotting with the indicated 579 antibodies. 580 
